Loading clinical trials...
Loading clinical trials...
A Phase 1b, Multicenter, Randomized, Blinded, Placebo-controlled Study to Evaluate the Efficacy of Guselkumab in Subjects With Familial Adenomatous Polyposis
Conditions
Interventions
Guselkumab
Placebo
Locations
32
United States
Mayo Clinic
Phoenix, Arizona, United States
City of Hope
Duarte, California, United States
Yale University
New Haven, Connecticut, United States
Mayo Clinic Jacksonville
Jacksonville, Florida, United States
University of Miami
Miami, Florida, United States
University of South Florida
Tampa, Florida, United States
Start Date
November 19, 2018
Primary Completion Date
September 13, 2021
Completion Date
March 23, 2022
Last Updated
February 3, 2025
NCT07463599
NCT02113202
NCT00585312
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions